| Income Statement |
| Total Revenue | 4.94M |
|
| Revenues (USD) | 4.94M |
| Cost of Revenue | 4.58M |
| Gross Profit | 366.00K |
| Operating Expenses | 15.66M |
| Research and Development Expense | 9.49M |
| Selling, General and Administrative Expense | 6.43M |
| Operating Income | -15.30M |
| Net Income | -13.93M |
| Net Income Common Stock | -13.93M |
| Net Income Common Stock (USD) | -13.93M |
| Consolidated Income | -13.93M |
| Earnings per Basic Share | -0.08 |
| Earnings per Basic Share (USD) | -0.08 |
| Earnings per Diluted Share | -0.08 |
| Earning Before Interest & Taxes (EBIT) | -13.93M |
| Earning Before Interest & Taxes (USD) | -13.93M |
| Weighted Average Shares | 178.44M |
| Weighted Average Shares Diluted | 178.44M |
| Balance Sheet |
| Cash and Equivalents | 13.17M |
| Cash and Equivalents (USD) | 13.17M |
| Investments | 119.22M |
| Investments Current | 51.01M |
| Investments Non-Current | 68.21M |
| Trade and Non-Trade Receivables | 2.67M |
| Current Assets | 71.63M |
| Property, Plant & Equipment Net | 38.76M |
| Total Assets | 179.59M |
| Debt Current | 2.47M |
| Total Debt | 3.05M |
| Current Liabilities | 9.43M |
| Debt Non-Current | 577.00K |
| Total Liabilities | 10.05M |
| Accumulated Retained Earnings (Deficit) | -232.66M |
| Shareholders Equity | 169.54M |
| Shareholders Equity (USD) | 169.54M |
| Assets Non-Current | 107.96M |
| Total Debt (USD) | 3.05M |
| Inventory | 1.16M |
| Liabilities Non-Current | 618.00K |
| Trade and Non-Trade Payables | 1.49M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 2.64M |
| Net Cash Flow from Financing | 1000 |
| Net Cash Flow / Change in Cash & Cash Equivalents | -7.10M |
| Capital Expenditure | 43.00K |
| Issuance (Purchase) of Equity Shares | 1000 |
| Net Cash Flow from Investing | -7.00K |
| Net Cash Flow - Investment Acquisitions and Disposals | -50.00K |
| Net Cash Flow from Operations | -7.09M |
| Share Based Compensation | 1.74M |